fda warning letter hims & hers compounded semaglutide september 2025 U.S. sends drug advertising letters to Lilly, Novo, The day after @potus announces

Peptides 108:3445

Heres whats coming soon, and whats in clinical trials: Orforglipron (brand name Foundayo): A once-daily oral GLP-1 was just approved by the FDA for weight loss, and will hopefully be approved for type 2 diabetes soon

The peptides selectivity may reduce unwanted observations, making it a compound of interest in studies exploring the modulation of growth hormone pathway

Ozempic Lawsuit vs

Could GPL-1 weight loss soon come in pill form

PlexusDx also provides optional Precision Peptide Genetic Testing ($99) to identify genetic variants in GLP1R, GIPR, and metabolic pathwayspersonalized insights that help optimize compound selection and dosing for thyroid patients whose metabolism may be compromised